Lysergic Acid | List of Frontiers open access articles

Original Research

Published on 16 Mar 2023

Increasing lysergic acid levels for ergot alkaloid biosynthesis: Directing catalysis via the F-G loop of Clavine oxidases

in Microbiotechnology

Li Rong Lim
Garrett Wong
Maybelle K. Go
Wen Shan Yew

Frontiers in Microbiology

doi 10.3389/fmicb.2023.1150937

4,244 views
5 citations

Original Research

Published on 25 Jan 2023

Construction of an efficient Claviceps paspali cell factory for lysergic acid production

in Industrial Biotechnology

Mingzhe Hu
Yu Zhou
Siyu Du
Xuan Zhang
Shen Tang
Yong Yang
Wei Zhang
Shaoxin Chen
Xuenian Huang
Xuefeng Lu

Frontiers in Bioengineering and Biotechnology

doi 10.3389/fbioe.2022.1093402

7,620 views
7 citations

Perspective

Published on 21 Nov 2023

Biological studies of clavine alkaloids targeting CNS receptors

in Psychopharmacology

Nikhil R. Tasker
Ethan J. Pazur
Peter Wipf

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1286941

4,944 views
5 citations

Case Report

Published on 03 Feb 2025

Treatment of neuropathic pain with repeated low-dose MDMA: a case report

in Psychopharmacology

Peter Gasser
Matthias E. Liechti
Friederike Holze

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1513022

14,981 views
1 citation

Review

Published on 02 Feb 2024

Effects of hallucinogenic drugs on the human heart

in Cardiovascular and Smooth Muscle Pharmacology

Joachim Neumann
Stefan Dhein
Uwe Kirchhefer
Britt Hofmann
Ulrich Gergs

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1334218

67,597 views
7 citations

Mini Review

Published on 21 Aug 2020

Psychedelics as a Treatment for Alzheimer’s Disease Dementia

Simon Andrew Vann Jones
Allison O’Kelly

Frontiers in Synaptic Neuroscience

doi 10.3389/fnsyn.2020.00034

286,423 views
52 citations

Case Report

Published on 24 Mar 2022

Pathological Delta Oscillations in Hallucinogen Persisting Perception Disorder: A Case Report

in Psychopharmacology

David Haslacher
Nikolina Novkovic
Maria Buthut
Andreas Heinz
Surjo R. Soekadar

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.867314

10,071 views
6 citations

Brief Research Report

Published on 23 May 2023

Systems-level analysis of local field potentials reveals differential effects of lysergic acid diethylamide and ketamine on neuronal activity and functional connectivity

in Brain Imaging Methods

Azat Nasretdinov
Sebastian A. Barrientos
Ivani Brys
Pär Halje
Per Petersson

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1175575

4,704 views
6 citations

Original Research

Published on 20 Jan 2023

Classic psychedelics do not affect T cell and monocyte immune responses

in Psychopharmacology

Deborah Rudin
Alexander Areesanan
Matthias E. Liechti
Carsten Gründemann

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1042440

13,493 views
8 citations

Original Research

Published on 03 Dec 2020

Acute Lysergic Acid Diethylamide Does Not Influence Reward-Driven Decision Making of C57BL/6 Mice in the Iowa Gambling Task

in Neuropharmacology

Lauri V. Elsilä
Nuppu Korhonen
Petri Hyytiä
Esa R. Korpi

Frontiers in Pharmacology

doi 10.3389/fphar.2020.602770

10,429 views
14 citations

Systematic Review

Published on 21 Jan 2020

Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials

in Psychopharmacology

Juan José Fuentes
Francina Fonseca
Matilde Elices
Magí Farré
Marta Torrens

Frontiers in Psychiatry

doi 10.3389/fpsyt.2019.00943

623,644 views
158 citations

Mini Review

Published on 27 Jan 2022

Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder

in Neuropharmacology

Athanasios Markopoulos
Antonio Inserra
Danilo De Gregorio
Gabriella Gobbi

Frontiers in Pharmacology

doi 10.3389/fphar.2021.749068

105,343 views
39 citations

Original Research

Published on 28 Jun 2017

A Single Dose of LSD Does Not Alter Gene Expression of the Serotonin 2A Receptor Gene (HTR2A) or Early Growth Response Genes (EGR1-3) in Healthy Subjects

in Neuropharmacology

Patrick C. Dolder
Edna Grünblatt
Felix Müller
Stefan J. Borgwardt
Matthias E. Liechti

Frontiers in Pharmacology

doi 10.3389/fphar.2017.00423

13,018 views
13 citations

Brief Research Report

Published on 31 Aug 2018

LSD Administered as a Single Dose Reduces Alcohol Consumption in C57BL/6J Mice

in Neuropharmacology

Kenneth Alper
Bin Dong
Relish Shah
Henry Sershen
K. Yaragudri Vinod

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00994

33,381 views
33 citations

Case Report

Published on 22 Oct 2020

Treatment of a Complex Personality Disorder Using Repeated Doses of LSD—A Case Report on Significant Improvements in the Absence of Acute Drug Effects

in Psychopharmacology

Felix Müller
Markus Mühlhauser
Friederike Holze
Undine E. Lang
Marc Walter
Matthias E. Liechti
Stefan Borgwardt

Frontiers in Psychiatry

doi 10.3389/fpsyt.2020.573953

72,388 views
17 citations

Review

Published on 13 Dec 2021

1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?

in Psychopharmacology

Sylvana Vilca-Melendez
Malin V. Uthaug
Julian L. Griffin

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.742856

9,349 views
5 citations

Articles

Increasing lysergic acid levels for ergot alkaloid biosynthesis: Directing catalysis via the F-G loop of Clavine oxidases

Construction of an efficient Claviceps paspali cell factory for lysergic acid production

Biological studies of clavine alkaloids targeting CNS receptors

Treatment of neuropathic pain with repeated low-dose MDMA: a case report

Effects of hallucinogenic drugs on the human heart

Psychedelics as a Treatment for Alzheimer’s Disease Dementia

Pathological Delta Oscillations in Hallucinogen Persisting Perception Disorder: A Case Report

Systems-level analysis of local field potentials reveals differential effects of lysergic acid diethylamide and ketamine on neuronal activity and functional connectivity

Classic psychedelics do not affect T cell and monocyte immune responses

Acute Lysergic Acid Diethylamide Does Not Influence Reward-Driven Decision Making of C57BL/6 Mice in the Iowa Gambling Task

Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials

Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder

A Single Dose of LSD Does Not Alter Gene Expression of the Serotonin 2A Receptor Gene (HTR2A) or Early Growth Response Genes (EGR1-3) in Healthy Subjects

LSD Administered as a Single Dose Reduces Alcohol Consumption in C57BL/6J Mice

Treatment of a Complex Personality Disorder Using Repeated Doses of LSD—A Case Report on Significant Improvements in the Absence of Acute Drug Effects

1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?